Clinical trials
HIV clinical trials
Below are recruiting hiv clinical trials, each written for real people, not researchers. We’re tracking 610 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06907056RecruitingPhase 4
A study on a simpler HIV medication combination
This study tests if a two-drug HIV regimen (darunavir/cobicistat plus lamivudine) works as well as a standard three-drug regimen in men whose HIV is already well-controlled. If effective, this could mean taking fewer medications.
Mexico City, Mexico CityAges 18–70 - NCT06962033Recruiting
Pride III: Prison and HIV prevention study
This study looks at ways to improve HIV prevention and treatment for people on probation who have injected opioids. Researchers want to learn from your experiences to help create better services.
New Haven, ConnecticutAges 18 years+ - NCT06967519RecruitingPhase 4
Optimizing malaria and HIV treatment in Africa
This study aims to find the best way to treat or prevent malaria in children with HIV. It may also help children without HIV who live in areas where malaria is common.
KampalaAges 5–17 - NCT06999928Recruiting
Enhanced mentor support for pregnant women with HIV
This study tests a program where trained 'mentor mothers' provide extra support to pregnant and postpartum women living with HIV and their babies. It aims to help women stay healthy and engaged in care.
Burnt Forest, Uasin Gishu CountyAges 18 years+ - NCT07040592RecruitingPhase 2
Semaglutide for HIV and alcohol use
This study is testing whether semaglutide, a medication already used for diabetes and weight loss, can help people with HIV who also have an alcohol use disorder cut back on drinking. It is for patients treated at the Atlanta VA Healthcare System.
Decatur, GeorgiaAges 18–99 - NCT07075146RecruitingPhase 3
Comparing two HIV treatments for people with overweight or obesity
This trial compares two different daily pill combinations for people newly starting HIV treatment who are overweight or have obesity. It aims to see which one works better for controlling the virus and managing weight.
Mexico CityAges 18–70 - NCT07105007Recruiting
Heart health program for older adults living with HIV
This study tests a special program to help people living with HIV improve their heart health through activity and healthy habits. If you have early signs of heart trouble and are not currently very active, this support may help you feel better and reduce your risk.
Seattle, WashingtonAges 40 years+ - NCT07112001Recruiting
Mobile app for anxiety and depression in HIV
This study tests a mobile health program to help people with HIV manage symptoms of anxiety and depression. It is designed to offer support through your phone and may improve your mood and overall health.
Gainesville, FloridaAges 18–90 - NCT07117370Recruiting
Coach Mpilo app for men with TB and HIV
This study tests a coaching app (Coach Mpilo) to help men in South Africa who are starting or restarting TB treatment, and for those who also have HIV but are not yet on HIV medication. The goal is to see if the app is helpful and usable.
East LondonAges 18 years+ - NCT07138144RecruitingPhase 4
Switching to a two-drug HIV pill vs. staying on three drugs
This study tests whether switching to a simpler, two-drug HIV pill (dolutegravir/lamivudine) is as safe and effective as staying on a three-drug regimen. It is for people whose HIV is already well-controlled and who are currently taking Biktarvy or Triumeq.
Mexico City, Mexico CityAges 18–70 - NCT07143968RecruitingPhase 2
Resmetirom for people with MASLD and HIV
This study tests if resmetirom can help people who have both HIV and a liver condition called MASLD (fat buildup in the liver not caused by alcohol). You may qualify if your liver has a certain amount of fat and stiffness, and your HIV is well controlled with stable medication.
Birmingham, AlabamaAges 18 years+ - NCT07160075RecruitingPhase 4
HIV prevention with PrEP for people on opioid therapy
This trial tests if daily PrEP medication can help prevent HIV in people receiving opioid replacement therapy. You must be HIV-negative and regularly attend your opioid treatment program to join.
Calgary, AlbertaAges 16 years+ - NCT07170748Recruiting
Testing a new blood test for HIV, hepatitis B/C, and syphilis
This study evaluates a new blood test that checks for HIV, hepatitis B, hepatitis C, and syphilis all at once. It is designed to see how well the test works in different groups of people, including those with known infections and those without.
AbidjanAges 18 years+ - NCT07177170Recruiting
Cancer screening: one visit vs. multiple visits for women with HIV
This study tests whether one or multiple clinic visits work better for cervical cancer screening in women living with HIV. It aims to see which approach is easier, more complete, and more acceptable.
FoumbanAges 25–49 - NCT07181278Recruiting
Better cervical cancer screening for women with HIV in Cameroon
This study tests a mobile team approach to screen for cervical cancer using HPV testing in women living with HIV. It aims to make screening easier to access and more effective.
BafoussamAges 25–49 - NCT07186244Recruiting
HIV Prevention Study for People Starting or Taking PrEP
This study is for people who are HIV-negative and want to take PrEP (a daily pill that prevents HIV). It will help researchers learn more about how to best support people taking PrEP in real-world settings.
Chieti, AbruzzoAges 18 years+ - NCT07221214RecruitingPhase 2
Testing a diabetes drug for drinking and heart health in HIV
This trial tests if a once-weekly diabetes medication (semaglutide) can help people with HIV reduce heavy drinking and improve heart health. It's for people who drink alcohol and have a higher body weight.
Nashville, TennesseeAges 18–89 - NCT07225530Recruiting
Screening and treatment for cervical cancer in women with HIV
This trial tests a program to screen and treat HIV-positive women for cervical cancer in La Romana, Dominican Republic. It may help catch and manage cervical cancer early.
La RomanaAges 25 years+ - NCT07270406Recruiting
Healthy habits for better sleep in people with HIV and pain
This study tests a healthy behaviors program to help prevent insomnia in people with HIV who also have ongoing pain. If you have trouble sleeping and chronic pain, this program may help improve your sleep and well-being.
St Louis, MissouriAges 25–65 - NCT07275606RecruitingPhase 1/Phase 2
Testing HIV prevention medicine cabotegravir in newborns
This study tests a long-acting injectable HIV prevention medicine called cabotegravir in newborn babies who were exposed to HIV. The goal is to see if it can help protect them from getting HIV.
Parow ValleyAges Up to 1 week - NCT07284082Recruiting
How Does Menopause and HIV Affect Heart Health in Women?
This study looks at how menopause and HIV together might affect a woman's risk for heart disease. If you are a woman with HIV and are either premenopausal, perimenopausal, or postmenopausal, the researchers want to see if the combination of HIV and menopause creates a higher risk.
San Francisco, CaliforniaAges 18 years+ - NCT07292792Recruiting
PrEP support through peer health navigation for people leaving jail
This study tests whether adding a peer health navigator (someone with lived experience who helps with health) to regular re-entry services can help more people learn about and start PrEP, a medicine that prevents HIV.
Dallas, TexasAges 18–99 - NCT07298785Recruiting
HIV prevention study led by peers for women
This study tests a peer-led approach to HIV prevention for women. It looks at whether having a peer (someone like you) help choose and use prevention tools can work better than standard care.
KampalaAges 15 years+ - NCT07303114Recruiting
HIV screening missed in general practice study
This study looks at missed chances for HIV testing in general doctor offices. It focuses on people who were diagnosed with HIV between 2021 and 2024.
StrasbourgAges 18 years+
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hiv?
- Yes. Clin2 currently lists 610 recruiting hiv studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hiv trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hiv trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.